Back to Awarded Treatment Trials
Awarded Trial: 02T-132
Grant ID
02T-132
Illness
Schizophrenia
Primary Drug/Intervention
Mifepristone
Primary Dosage
800 mg/day
Secondary Drug Intervention
Haloperidol
Secondary Dosage
10 mg/day
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Verdoux
Sample Size
80
Duration of Study Period for Each Subject
4 weeks
Outcome Measurements
PANSS, CGI, Simpson-Angus Scale
Results
Study terminated in August 2003 due to poor enrollment.
Publication
N/A
Link
N/A
PI Name
Helene Verdoux
Degree
MD
Center
Association pour la Recherche Medicale en Aquitaine (ARMA)
Institution
University Victor Segalen Bordeaux 2
Address
146, rue Leo Saignat
City or Town
Bordeaux
State or Province
N/A
Zip or Postal Code
33076
Country
France
Email Address
helene.verdoux@perrens.aquisante.fr